This inventor holds 3 USPTO granted patents and 3 published patent applications. Top assignee: Korea Institute of Science and Technology. Active years: 2019-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2023
Title: Innovations of Man Kyu Shim in Cancer Immunotherapy
Introduction
Man Kyu Shim is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer immunotherapy, holding three patents that focus on innovative approaches to combat cancer. His work emphasizes the development of advanced therapeutic agents that enhance the body's immune response against tumors.
Latest Patents
One of his latest patents is titled "Visible light-activatable nanoparticles for cancer immunotherapy and use thereof." This invention discloses self-assembled nanoparticles that can induce potent apoptosis in cancer cells while increasing their own anticancer immunogenicity. This dual action maximizes the therapeutic efficacy for cancer treatment. Another notable patent is a "Pharmaceutical composition for combination therapy for preventing or treating cancer containing tumor-specific drug conjugate and anti-PD-L1 antibody as active ingredients." This composition significantly inhibits cancer growth in in-vivo experiments and enhances the immunotherapeutic effect by activating immune cells in cancerous tissues. It boasts superior tumor accumulation efficiency and selectivity compared to existing anticancer agents, while maintaining stability and low toxicity to normal tissues.
Career Highlights
Man Kyu Shim is affiliated with the Korea Institute of Science and Technology, where he conducts his research and development activities. His work has garnered attention for its innovative approach to cancer treatment, positioning him as a key figure in the field of biomedical research.
Collaborations
He collaborates with notable colleagues, including Kwangmeyung Kim and Ju Hee Ryu, who contribute to his research endeavors and help advance the development of his patented technologies.
Conclusion
Man Kyu Shim's innovative work in cancer immunotherapy showcases the potential of advanced therapeutic strategies to improve treatment outcomes for patients. His patents reflect a commitment to enhancing the efficacy and safety of cancer therapies, making significant strides in the fight against this disease.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile